HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Artificial Intelligence and Big Data in Cancer

Artificial Intelligence and Big Data in Cancer

Artificial intelligence (AI) and big data have emerged as transformative forces in cancer research and treatment. AI-driven algorithms can sift through enormous datasets, including patient health records, genetic information, and imaging data, to identify patterns and make predictions that would otherwise be difficult to detect. By leveraging big data, AI systems can pinpoint biomarkers that are crucial for early cancer detection, track the progression of disease, and suggest the most effective treatment options. Moreover, AI facilitates the development of novel drugs by predicting how compounds will interact with cancer cells. Together, AI and big data are helping to accelerate the pace of research, enhance clinical decision-making, and bring us closer to more personalized and effective cancer therapies.

Committee Members
Committee Member - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Committee Member - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Tags

Submit your abstract Today

YouTube
WhatsAppWhatsApp